VBI Vaccines Inc/BC Retained Earnings
VBI Vaccines Inc/BC had Retained Earnings of -$600.35 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-05-15
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$600.35M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$582.45M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$582.43M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$561.99M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-03-31 | -$600.35M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$582.45M 10-Q · filed 2024-05-15 |
| 2023-09-30 | -$582.43M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$561.99M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$517.36M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$489.61M 10-K · filed 2024-04-16 |
| 2022-09-30 | -$468.47M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$443.26M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$397.56M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$378.37M 10-K · filed 2023-03-13 |
| 2021-09-30 | -$359.59M 10-Q · filed 2021-11-08 |
| 2021-06-30 | -$343.74M 10-Q · filed 2021-08-02 |
| 2021-03-31 | -$326.26M 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$308.62M 10-K · filed 2022-03-07 |
| 2020-09-30 | -$293.26M 10-Q · filed 2020-11-02 |
| 2020-06-30 | -$280.26M 10-Q · filed 2020-07-31 |
| 2020-03-31 | -$270.75M 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$262.39M 10-K · filed 2021-03-02 |
| 2019-09-30 | -$251.51M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$235.35M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$222.18M 10-Q · filed 2019-05-01 |
| 2018-12-31 | -$207.57M 10-K · filed 2020-03-05 |
| 2018-09-30 | -$188.32M 10-Q · filed 2018-11-09 |
| 2018-06-30 | -$172.96M 10-Q · filed 2018-07-26 |
| 2018-03-31 | -$156.23M 10-Q · filed 2018-05-01 |
| 2017-12-31 | -$143.97M 10-K · filed 2019-02-25 |
| 2017-09-30 | -$132.43M 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$122.63M 10-Q · filed 2017-07-31 |
| 2017-03-31 | -$113.62M 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$104.98M 10-K · filed 2018-02-26 |
| 2015-12-31 | -$81.78M 10-K · filed 2017-03-20 |